Endothelin-1 reduces P-glycoprotein transport activity in an in vitro model of human adult blood-brain barrier

Cellular and Molecular Neurobiology

Volumn 28, Issue 7, 2008, Pages 915-921

  Hembury, Alexandra ^a   Mabondzo, Aloïse ^a  

^a SERVICE DE CHIMIE BIOORGANIQUE ET DE MARQUAGE   (France)

Author keywords

Blood brain barrier (BBB); Endothelin 1 (ET 1); P glycoprotein (Pgp)

Indexed keywords

ANTIBODY; DIGOXIN; ENDOTHELIN 1; GLYCOPROTEIN P;

ARTICLE; BLOOD BRAIN BARRIER; CELL CULTURE; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; ENCEPHALITIS; ENDOTHELIUM CELL; FLOW CYTOMETRY; GLIA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MICROVASCULARIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AGE FACTORS; ANTIBODY SPECIFICITY; BIOLOGICAL TRANSPORT, ACTIVE; BLOOD-BRAIN BARRIER; CELLS, CULTURED; COCULTURE TECHNIQUES; DIGOXIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; ENDOTHELIN-1; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MODELS, BIOLOGICAL; NEUROGLIA; P-GLYCOPROTEIN;

ANIMALIA;

EID: 55049099747     PISSN: 02724340     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10571-008-9277-y     Document Type: Article

References (54)

1. H Arai S Hori I Aramori H Ohkubo S Nakanishi 1990 Cloning and expression of a cDNA encoding an endothelin receptor Nature 348 730 732
2. A Bagnato L Rosano F Spinella V Di Castro R Tecce PG Natali 2004 Endothelin B receptor blockade inhibits dynamics of cell interactions and communications in melanoma cell progression Cancer Res 64 1436 1443
3. P Ballabh A Braun M Nedergaard 2004 The blood-brain barrier: an overview: structure, regulation, and clinical implications Neurobiol Dis 16 1 13
4. FC Barone RN Willette TL Yue G Feurestein 1995 Therapeutic effects of endothelin receptor antagonists in stroke Neurol Res 17 259 264
5. B Bauer AM Hartz DS Miller 2007 Tumor necrosis factor alpha and endothelin-1 increase P-glycoprotein expression and transport activity at the blood-brain barrier Mol Pharmacol 71 667 675
6. A Chauhan S Hahn S Gartner CA Pardo SK Netesan J McArthur A Nath 2007 Molecular programming of endothelin-1 in HIV-infected brain: role of Tat in up-regulation of ET-1 and its inhibition by statins FASEB J 21 777 789
7. JR Cirrito R Deane AM Fagan ML Spinner M Parsadanian MB Finn H Jiang JL Prior A Sagare KR Bales SM Paul BV Zlokovic D Piwnica-Worms DM Holtzman 2005 P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model J Clin Invest 115 3285 3290
8. C Cordon-Cardo JP O'Brien D Casals L Rittman-Grauer JL Biedler MR Melamed JR Bertino 1989 Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites Proc Natl Acad Sci USA 86 695 698
9. HE de Vries J Kuiper AG de Boer TJ Van Berkel DD Breimer 1997 The blood-brain barrier in neuroinflammatory diseases Pharmacol Rev 49 143 155
10. N Didier WA Banks C Creminon N Reuddre-Bosquet A Mabondzo 2002 HIV-1-induced production of endothelin-1 in an in vitro model of the human blood-brain barrier Neuroreport 13 1179 1183
11. N Didier IA Romero C Creminon A Wijkhuisen J Grassi A Mabondzo 2003 Secretion of interleukin-1beta by astrocytes mediates endothelin-1 and tumour necrosis factor-alpha effects on human brain microvascular endothelial cell permeability J Neurochem 86 246 254
12. H Ehrenreich T Costa KA Clouse RM Pluta Y Ogino JE Coligan PR Burd 1993 Thrombin is a regulator of astrocytic endothelin-1 Brain Res 600 201 207
13. C Fernandez M Buyse M German-Fattal F Gimenez 2004 Influence of the pro-inflammatory cytokines on P-glycoprotein expression and functionality J Pharm Pharm Sci 7 359 371
14. KB Goralski G Hartmann M Piquette-Miller KW Renton 2003 Downregulation of mdr1a expression in the brain and liver during CNS inflammation alters the in vivo disposition of digoxin Br J Pharmacol 139 35 48
15. B Hagenbuch B Gao PJ Meier 2002 Transport of xenobiotics across the blood-brain barrier News Physiol Sci 17 231 234
16. AM Hartz B Bauer G Fricker DS Miller 2004 Rapid regulation of P-glycoprotein at the blood-brain barrier by endothelin-1 Mol Pharmacol 66 387 394
17. RA Hawkins RL O'Kane IA Simpson JR Vina 2006 Structure of the blood-brain barrier and its role in the transport of amino acids J Nutr 136 218S 226S
18. VY Hebert BL Crenshaw RL Romanoff VP Ekshyyan TR Dugas 2004 Effects of HIV drug combinations on endothelin-1 and vascular cell proliferation Cardiovasc Toxicol 4 117 131
19. B Jiang VY Hebert JH Zavecz TR Dugas 2006 Antiretrovirals induce direct endothelial dysfunction in vivo J Acquir Immune Defic Syndr 42 391 395
20. V Josserand H Pelerin B de Bruin B Jego B Kuhnast F Hinnen F Duconge R Boisgard F Beuvon F Chassoux C umas-Duport E Ezan F Dolle A Mabondzo B Tavitian 2006 Evaluation of drug penetration into the brain: a double study by in vivo imaging with positron emission tomography and using an in vitro model of the human blood-brain barrier J Pharmacol Exp Ther 316 79 86
21. JH Kim JH Kim JA Park SW Lee WJ Kim YS Yu KW Kim 2006 Blood-neural barrier: intercellular communication at glio-vascular interface J Biochem Mol Biol 39 339 345
22. T Kodawara S Masuda H Wakasugi Y Uwai T Futami H Saito T Abe K Inu 2002 Organic anion transporter oatp2-mediated interaction between digoxin and amiodarone in the rat liver Pharm Res 19 738 743
23. W Loscher H Potschka 2005 Drug resistance in brain diseases and the role of drug efflux transporters Nat Rev Neurosci 6 591 602
24. W Loscher H Potschka 2005 Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases Prog Neurobiol 76 22 76
25. CR Mangahas GV la Cruz G Friedman-Jimenez S Jamal 2005 Endothelin-1 induces CXCL1 and CXCL8 secretion in human melanoma cells J Invest Dermatol 125 307 311
26. I Megard A Garrigues S Orlowski S Jorajuria P Clayette E Ezan A Mabondzo 2002 A co-culture-based model of human blood-brain barrier: application to active transport of indinavir and in vivo-in vitro correlation Brain Res 927 153 167
27. T Mikkaichi T Suzuki T Onogawa M Tanemoto H Mizutamari M Okada T Chaki S Masuda T Tokui N Eto M Abe F Satoh M Unno T Hishinuma K Inui S Ito J Goto T Abe 2004 Isolation and characterization of a digoxin transporter and its rat homologue expressed in the kidney Proc Natl Acad Sci USA 101 3569 3574
28. A Milane C Fernandez S Vautier G Bensimon V Meininger R Farinotti 2007 Minocycline and riluzole brain disposition: interactions with p-glycoprotein at the blood-brain barrier J Neurochem 103 164 173
29. ET Morgan KB Goralski M Piquette-Miller KW Renton GR Robertson MR Chaluvadi KA Charles SJ Clarke M Kacevska C Liddle TA Richardson R Sharma CJ Sinal 2008 Regulation of drug-metabolizing enzymes and transporters in infection, inflammation, and cancer Drug Metab Dispos 36 205 216
30. M Nakajima S Morimoto S Takamoto S Kitano K Fukuo T Onishi T Ogihara 1994 Endothelin-1 in cerebrospinal fluid in elderly patients with hypertension and dementia Hypertension 24 97 100
31. XJ Nie Y Olsson 1996 Endothelin peptides in brain diseases Rev Neurosci 7 177 186
32. WM Pardridge 2007 Blood-brain barrier delivery Drug Discov Today 12 54 61
33. JW Polli JL Jarrett SD Studenberg JE Humphreys SW Dennis KR Brouwer JL Woolley 1999 Role of P-glycoprotein on the CNS disposition of amprenavir (141W94), an HIV protease inhibitor Pharm Res 16 1206 1212
34. F Porcheray S Viaud AC Rimaniol C Leone B Samah N Reuddre-Bosquet D Dormont G Gras 2005 Macrophage activation switching: an asset for the resolution of inflammation Clin Exp Immunol 142 481 489
35. J Rautio JE Humphreys LO Webster A Balakrishnan JP Keogh JR Kunta CJ Serabjit-Singh JW Polli 2006 In vitro p-glycoprotein inhibition assays for assessment of clinical drug interaction potential of new drug candidates: a recommendation for probe substrates Drug Metab Dispos 34 786 792
36. B Rolinski A Heigermoser E Lederer JR Bogner O Loch FD Goebel 1999 Endothelin-1 is elevated in the cerebrospinal fluid of HIV-infected patients with encephalopathy Infection 27 244 247
37. PT Ronaldson R Bendayan 2006 HIV-1 viral envelope glycoprotein gp120 triggers an inflammatory response in cultured rat astrocytes and regulates the functional expression of P-glycoprotein Mol Pharmacol 70 1087 1098
38. C Saengkhae M Salerno D Ades A Siove L Le Moyeca V Migonney A Garnier-Suillerot 2007 Ability of carbazole salts, inhibitors of Alzheimer beta-amyloid fibril formation, to cross cellular membranes Eur J Pharmacol 559 124 131
39. T Sakurai M Yanagisawa Y Takuwa H Miyazaki S Kimura K Goto T Masaki 1990 Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor Nature 348 732 735
40. Y Sasaki M Takimoto K Oda T Fruh M Takai T Okada S Hori 1997 Endothelin evokes efflux of glutamate in cultures of rat astrocytes J Neurochem 68 2194 2200
41. S Schinelli 2006 Pharmacology and physiopathology of the brain endothelin system: an overview Curr Med Chem 13 627 638
42. M Schwartz O Butovsky J Kipnis 2006 Does inflammation in an autoimmune disease differ from inflammation in neurodegenerative diseases? Possible implications for therapy J Neuroimmune Pharmacol 1 4 10
43. G Shirakami K Nakao Y Saito T Magaribuchi M Mukoyama H Arai K Hosoda S Suga K Mori H Imura 1993 Low doses of endothelin-1 inhibit atrial natriuretic peptide secretion Endocrinology 132 1905 1912
44. L Speciale M Sarasella S Ruzzante D Caputo R Mancuso MG Calvo FR Guerini P Ferrante 2000 Endothelin and nitric oxide levels in cerebrospinal fluid of patients with multiple sclerosis J Neurovirol 6 Suppl 2 S62 S66
45. R Suzuki H Masaoka Y Hirata F Marumo E Isotani K Hirakawa 1992 The role of endothelin-1 in the origin of cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage J Neurosurg 77 96 100
46. Y Takuwa M Yanagisawa N Takuwa T Masaki 1989 Endothelin, its diverse biological activities and mechanisms of action Prog Growth Factor Res 1 195 206
47. MG Tansey TC Frank-Cannon MK McCoy JK Lee TN Martinez FE McAlpine KA Ruhn TA Tran 2008 Neuroinflammation in Parkinson's disease: is there sufficient evidence for mechanism-based interventional therapy? Front Biosci 13 709 717
48. T Tatsuta M Naito T Oh-hara I Sugawara T Tsuruo 1992 Functional involvement of P-glycoprotein in blood-brain barrier J Biol Chem 267 20383 20391
49. D Theron S de Barraud S Tardivel H Pelerin P Demeuse C Mercier A Mabondzo R Farinotti B Lacour F Roux F Gimenez 2003 Influence of tumor necrosis factor-alpha on the expression and function of P-glycoprotein in an immortalised rat brain capillary endothelial cell line, GPNT Biochem Pharmacol 66 579 587
50. M Uhr M Ebinger MC Rosenhagen MT Grauer 2005 The anti-Parkinson drug budipine is exported actively out of the brain by P-glycoprotein in mice Neurosci Lett 383 73 76
51. CE Wright JR Fozard 1988 Regional vasodilation is a prominent feature of the haemodynamic response to endothelin in anaesthetized, spontaneously hypertensive rats Eur J Pharmacol 155 201 203
52. M Yanagisawa H Kurihara S Kimura Y Tomobe M Kobayashi Y Mitsui Y Yazaki K Goto T Masaki 1988 A novel potent vasoconstrictor peptide produced by vascular endothelial cells Nature 332 411 415
53. S Yoshimoto Y Ishizaki H Kurihara T Sasaki M Yoshizumi M Yanagisawa Y Yazaki T Masaki K Takakura S Murota 1990 Cerebral microvessel endothelium is producing endothelin Brain Res 508 283 285
54. I Ziv G Fleminger R Djaldetti A Achiron E Melamed M Sokolovsky 1992 Increased plasma endothelin-1 in acute ischemic stroke Stroke 23 1014 1016